Neurofilament light chain in serum of cancer patients with acute neurological complications
Aim: Neurofilament light chain (NfL) is a nonspecific sensitive biomarker of axonal damage.Methods: This case series identified cancer patients with neurological complications who had serum NfL measurements and paired these results to outcomes.Results: NfL serum levels were available in 15 patients...
Saved in:
| Main Authors: | Amulya Gottiparthy, Keng Lam, Suprateek Kundu, Zixi Yang, Ivo Tremont-Lukats, Sudhakar Tummala |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | CNS Oncology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20450907.2024.2386233 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of ethylene oxide exposure with serum neurofilament light chain levels among American adults
by: Xiuwen Yang, et al.
Published: (2025-03-01) -
Neurological complications of solid organ transplantation
by: José Luiz Pedroso, et al. -
Stem cells use in the treatment of neurologic disorders: Has the future already arrived?
by: Obradović Dragana, et al.
Published: (2008-01-01) -
Associations between blood selenium and serum neurofilament light chain: results of a nationwide survey
by: Yayun Liao, et al.
Published: (2025-04-01) -
Recommendations on neurologic, cognitive, and psychiatric manifestations in patients with Sjögren’s disease by the Brazilian Society of Rheumatology
by: Fabiola Reis de Oliveira, et al.
Published: (2025-02-01)